In stock COA-25%
Low stock COA DOCUMENT SLOT-25%
Growth ResearchCJC-1295 (with DAC)
Modified GHRH analog with Drug Affinity Complex (DAC), studied for sustained growth hormone release in research models.
Research catalogueLaboratory-use positioning
Batch documentationBatch certificate supplied with order
Order trackingFrom payment to dispatch
Product information
CompoundCJC-1295 (with DAC)
Presentation5mg vial
CategoryGrowth Research
AvailabilityLow stock
Batch COACertificate supplied with order
You save €32.90 on this presentation — an extra 10% off when you pay with crypto.
For research use only. Not for human consumption, diagnostic, therapeutic or veterinary use.
Overview
CJC-1295 with DAC is a synthetic analog of growth hormone-releasing hormone (GHRH, amino acids 1-29) modified with a Drug Affinity Complex. The DAC extension allows covalent binding to serum albumin after injection, significantly extending its half-life from minutes to approximately 6-8 days in research models. This prolonged activity profile enables sustained elevation of growth hormone and IGF-1 levels, making it a widely studied compound in endocrinology and growth factor research.
Mechanism of Action
CJC-1295 binds to GHRH receptors on anterior pituitary somatotroph cells, stimulating adenylate cyclase and increasing intracellular cAMP levels. This triggers the release of stored growth hormone in a pulsatile pattern that preserves physiological secretion rhythms. The DAC moiety forms a stable bond with circulating albumin via reactive lysine residues, shielding the peptide from enzymatic degradation (DPP-IV) and renal clearance, thereby extending its plasma residence time.
Research Applications
- Growth hormone axis research and GH secretion kinetics
- IGF-1 pathway signalling studies
- Sustained-release peptide pharmacokinetics
- Body composition research in preclinical models
- Pituitary function and somatotroph cell biology
FREE TOOL
Reconstitution calculator
Enter your reconstitution to get the draw volume for CJC-1295 (with DAC).
Concentration2.50 mg/ml
Draw volume0.100 ml
On the syringe10.0 units
Doses per vial20
10units
Pull the plunger to 10.0 units on a 1 ml U‑100 syringe0.100 ml · 2.50 mg/ml · 20 doses per vial
Concentration = peptide mass ÷ water volume. Unit readings assume U-100 insulin syringes, graduated 100 units per millilitre. For laboratory calculation only — not dosing guidance.